Patent Expiry: Opening the Generics Floodgates The patent protection covering semaglutide will begin lapsing in several major jurisdictions from March 2026 , a turning point that opens the field to generic competition in many regions including India, Brazil, and Canada
Rapid heart rate that does not slow with rest
Examples of DPP-4 inhibitors include sitagliptin (Januvia), linagliptin (Tradjenta), saxagliptin (Onglyza), and alogliptin (Nesina)
The SURPASS-2 trial, [which] checked head-to-head tirzepatide and semaglutide, results indicated that most common side effects were not significantly different between tirzepatide and semaglutide, Dr
GLP-1 medicines mainly reduce hunger and slow movement through the stomach after meals
This low starting dose allows the body to adapt gradually before the dose is increased in a stepwise fashion over several months